Caplin Point Laboratories is a fast-growing and fully integrated pharmaceutical company with a dominant presence in Latin America and Francophone Africa, alongside a growing footprint in regulated markets such as the USA and EU. Established in 1990, the company began its journey by manufacturing a diverse range of ointments, creams, and other external applications. Caplin Point Laboratories was listed in 1994 following an oversubscribed Initial Public Offering (IPO), which facilitated the establishment of a manufacturing facility in Pondicherry. Since then, the company has progressively expanded its product range and capabilities.

Services include:
- Finished Dosage Forms
- Regulatory Services
- Solid Dosage
- Non Sterile Dosage
- Injectables
- Packaging
- Analytical Services
- Containment

Caplin Point Laboratories continues to innovate within the pharmaceutical industry, enhancing its offerings to meet the needs of its clients. For more information, please visit caplinpoint.net.